📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial. (2017)

First Author: Pugh S

Attributed to: The role of miR-31 in regulating response of colorectal cancer to EGFR inhibition - relationship to the detriment observed in the New EPOC study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.21291

PubMed Identifier: 29212194

Publication URI: http://europepmc.org/abstract/MED/29212194

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 55

ISSN: 1949-2553